2020
DOI: 10.1007/s13233-020-8052-x
|View full text |Cite
|
Sign up to set email alerts
|

Enzymatically Crosslinkable Hyaluronic Acid-Gelatin Hybrid Hydrogels as Potential Bioinks for Tissue Regeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(23 citation statements)
references
References 37 publications
0
23
0
Order By: Relevance
“…Application Reference HA 1 -collagen matrix cartilage tissue repair and neural regeneration [40,41] HA-gelatin hydrogels bone regeneration and chondrogenic differentiation [42][43][44][45] HA-CHI 2 composite cartilage TE [36,46,47] oxi-HA-resveratrol hydrogel cell carrier for chondrocytes [48,49] PGS-PCL-Me-HA heart valve TE [50] Alginate-HA myocardial TE [51] thiolated-HA hydrogels Adipose-substitutes TE [52][53][54] collagen-PEG-grafted-HA intradermal drug delivery [55] oxi-HA-gelatin microspheres drug delivery [56] HA-g-poly-(HEMA) lung TE [57] HA-ADH 3 -EDCI 4 drug delivery [58,59] HA-DVS 5 viscosupplement [60,61] HA-BDDE 6 viscosupplement [62][63][64] HA-PRP 7 regenerative medicine [65][66][67] 1 hyaluronic acid, 2 chitosan, 3 adipic dihydrazide, 4 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide, 5 divinyl sulfone, 6 1,4-butanediol diglycidyl ether, 7 platelet-rich plasma, TE-tissue engineering.…”
Section: Biomaterialsmentioning
confidence: 99%
“…Application Reference HA 1 -collagen matrix cartilage tissue repair and neural regeneration [40,41] HA-gelatin hydrogels bone regeneration and chondrogenic differentiation [42][43][44][45] HA-CHI 2 composite cartilage TE [36,46,47] oxi-HA-resveratrol hydrogel cell carrier for chondrocytes [48,49] PGS-PCL-Me-HA heart valve TE [50] Alginate-HA myocardial TE [51] thiolated-HA hydrogels Adipose-substitutes TE [52][53][54] collagen-PEG-grafted-HA intradermal drug delivery [55] oxi-HA-gelatin microspheres drug delivery [56] HA-g-poly-(HEMA) lung TE [57] HA-ADH 3 -EDCI 4 drug delivery [58,59] HA-DVS 5 viscosupplement [60,61] HA-BDDE 6 viscosupplement [62][63][64] HA-PRP 7 regenerative medicine [65][66][67] 1 hyaluronic acid, 2 chitosan, 3 adipic dihydrazide, 4 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide, 5 divinyl sulfone, 6 1,4-butanediol diglycidyl ether, 7 platelet-rich plasma, TE-tissue engineering.…”
Section: Biomaterialsmentioning
confidence: 99%
“…Polymeric hydrogels, a 3D hydrophilic polymer network, have been highlighted as an attractive candidate for 3D bioink materials owing to their structural and chemical similarity to the natural ECMs, simplicity of physicochemical modulation, and easy encapsulation of various therapeutic agents (i.e., drugs, genes, peptides, proteins, and cells). In particular, in situ cross-linkable hydrogels have been used extensively as bioinks, which show a sol-to-gel phase transition via various physical and chemical cross-linking reactions. The target cells can be encapsulated easily within hydrogel matrices during in situ hydrogel formation. Although various in situ forming hydrogels have been developed as bioinks, the production of advanced bioink materials for precisely recapitulating ECM is still a challenge due to the complexity of native tissues and the delineation of intrinsic properties of laden cells.…”
mentioning
confidence: 99%
“…41 Thus, enzymolysis was selected as driving force to induce peptide bond breakage within hydrogel. 42 Figure 5(b) shows the degradation profiles of different hydrogels in PBS solution containing 6 μg/mL collagenase at 37°C. Though these kinds of hydrogels present distinct degradation behavior, they can completely degrade after 72 h, suggesting quick biodegradability of these hydrogels in human body.
Figure 5.(a) Swelling ratios of various hydrogels in phosphate buffer solution (pH 7.4) at 37 °C, and (b) degradation behavior of different hydrogels.
…”
Section: Resultsmentioning
confidence: 99%